Technical Trend Overview and Price Movement
The stock closed at ₹354.95 on 4 Aug 2026, down 1.09% from the previous close of ₹358.85. Intraday volatility saw a high of ₹361.20 and a low of ₹350.20, indicating a relatively narrow trading range. Over the past week, Gujarat Themis Biosyn has underperformed the broader market, with a 1-week return of -1.58% compared to the Sensex’s 2.35% gain. This underperformance extends to longer horizons, with a 1-month return of -8.12% against the Sensex’s 1.13%, and a year-to-date decline of -19.78% versus the Sensex’s -7.72%.
Despite these short-term setbacks, the stock’s long-term performance remains impressive, boasting a 3-year return of 230.22%, a 5-year return of 538.06%, and a remarkable 10-year return of 5127.54%, significantly outpacing the Sensex’s respective returns of 20.54%, 46.11%, and 183.92%. This disparity highlights the stock’s historical growth potential, albeit tempered by recent technical challenges.
MACD and Momentum Indicators Signal Bearish Bias
The Moving Average Convergence Divergence (MACD) indicator presents a mildly bearish outlook on both weekly and monthly timeframes. This suggests that the stock’s upward momentum has weakened, with the MACD line likely crossing below the signal line or remaining below it, signalling potential downside pressure. The bearish MACD aligns with the recent price decline and the shift to a sideways trend, indicating that bullish momentum is not currently dominant.
Complementing the MACD, the Know Sure Thing (KST) oscillator also reflects a mildly bearish stance on weekly and monthly charts. The KST’s negative readings reinforce the notion of waning momentum, suggesting that the stock may face continued resistance in regaining upward traction in the near term.
RSI and Bollinger Bands Paint a Mixed Picture
The Relative Strength Index (RSI) remains neutral on both weekly and monthly scales, providing no clear buy or sell signals. This lack of directional bias from the RSI indicates that the stock is neither overbought nor oversold, consistent with the sideways technical trend.
Bollinger Bands, however, offer a nuanced view. On the weekly timeframe, the bands signal bearishness, likely due to the stock price approaching or breaching the lower band, which often reflects increased volatility and downward pressure. Conversely, the monthly Bollinger Bands suggest a mildly bullish environment, implying that over a longer horizon, the stock may still retain some upside potential or mean reversion prospects.
Moving Averages and Volume Trends
Daily moving averages provide a mildly bullish indication, suggesting that short-term price averages remain above longer-term averages, or that the stock is holding key support levels. This mild bullishness contrasts with the broader sideways trend and bearish momentum indicators, signalling a potential tug-of-war between buyers and sellers.
Volume-based indicators such as On-Balance Volume (OBV) show no discernible trend on weekly or monthly charts, indicating that trading volumes have not decisively supported either accumulation or distribution phases. This volume neutrality further corroborates the sideways price action and lack of strong conviction among market participants.
Just made the cut! This Mid Cap from the Heavy Electrical Equipment sector entered our elite Top 1% list recently. Discover it before the crowd catches on!
- - Top-rated across platform
- - Strong price momentum
- - Near-term growth potential
Dow Theory and Market Sentiment
According to Dow Theory assessments, Gujarat Themis Biosyn exhibits no clear trend on weekly or monthly timeframes. This absence of a definitive trend aligns with the sideways technical stance and suggests that the stock is currently in a consolidation phase. Investors should be cautious as the lack of trend clarity often precedes significant directional moves, either upward or downward.
Mojo Score and Rating Update
MarketsMOJO’s latest evaluation assigns Gujarat Themis Biosyn a Mojo Score of 40.0, categorising it as a 'Sell' with a recent downgrade from a previous 'Hold' rating on 3 Aug 2026. This downgrade reflects the deteriorating technical parameters and the shift in momentum, signalling increased risk for investors holding the stock at current levels. The company remains classified as a small-cap within the Pharmaceuticals & Biotechnology sector, which typically entails higher volatility and sensitivity to sector-specific developments.
Valuation Context and Price Range
The stock’s current price of ₹354.95 is significantly below its 52-week high of ₹479.45, indicating a correction of approximately 26%. However, it remains comfortably above the 52-week low of ₹225.75, suggesting some resilience amid sector headwinds. This price range highlights the stock’s volatility and the importance of technical signals in guiding near-term trading decisions.
Holding Gujarat Themis Biosyn Ltd from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Takeaway and Outlook
Gujarat Themis Biosyn Ltd’s recent technical parameter changes underscore a cautious outlook for investors. The shift from mildly bullish to sideways trend, combined with bearish MACD and KST signals, suggests that the stock may face near-term headwinds. The neutral RSI and mixed Bollinger Bands readings indicate a lack of clear directional momentum, while daily moving averages provide a modest bullish counterbalance.
Given the downgrade to a 'Sell' rating and the stock’s underperformance relative to the Sensex over recent weeks and months, investors should carefully monitor key support levels around ₹350 and watch for any confirmation of trend reversal or further deterioration. The absence of strong volume trends and Dow Theory signals implies that a decisive move may be pending, but the direction remains uncertain.
Long-term investors may find comfort in the stock’s robust multi-year returns, but short-term traders should exercise prudence and consider alternative opportunities within the Pharmaceuticals & Biotechnology sector or broader market.
Summary of Technical Indicators:
- MACD: Weekly and Monthly - Mildly Bearish
- RSI: Weekly and Monthly - No Signal
- Bollinger Bands: Weekly - Bearish; Monthly - Mildly Bullish
- Moving Averages (Daily) - Mildly Bullish
- KST: Weekly and Monthly - Mildly Bearish
- Dow Theory: Weekly and Monthly - No Trend
- OBV: Weekly and Monthly - No Trend
Investors should weigh these mixed signals carefully and consider the broader market context before making allocation decisions involving Gujarat Themis Biosyn Ltd.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
